Takeda Will Settle Actos Lawsuits for $2.4 Billion

Thousands of Actos Lawsuits Reach Settlement Amount of $2.4 BillionAfter years of Actos lawsuits over the side effects of the Type 2 diabetes drug, Japanese pharmaceutical company Takeda recently offered a settlement the matter by distributing a total of $2.2 billion to thousands of personal injury and wrongful death lawsuits consolidated into … [Read more...]

Plaintiff Awarded $2.3 Million for Actos Bladder Cancer

Takeda Pharmaceuticals Loses Another Actos Bladder Cancer LawsuitTakeda Pharmaceuticals must pay another penalty, this time $2.3 million, for Actos bladder cancer injuries caused by the blockbuster Type 2 diabetes drug Actos, which has been tied to bladder cancer in numerous patients.On Thursday, February 12th, plaintiff John Kristufek was … [Read more...]

Actos Bladder Cancer Trials Focus On Causation

Two New Plaintiffs Assert Actos Bladder Cancer ClaimsTwo lawsuits in state court claim that Actos led to the development of bladder cancer, and in one case, the victim’s death.The family of Moshe Bitton filed a wrongful death lawsuit against Actos manufacturer Takeda Pharmaceuticals and their American subsidiaries, claiming that taking the drug … [Read more...]

Plaintiff Awarded Damages in Actos Bladder Cancer Trial

Jury Rules In Favor of Plaintiff in Actos Bladder Cancer TrialAlthough Takeda Pharmaceuticals argued that a plaintiff’s life style choices, including smoking, caused her bladder cancer, on Friday, October 3rd, ruled in favor of Frances Wisniewski’s claim in the bladder cancer trial that Actos injured her.Wisniewski was prescribed Actos to treat … [Read more...]

Along with Bladder Cancer, Actos Can Also Cause Bone Fractures

Women Who Took Actos for Diabetes More Susceptible to Bone Fractures Takeda Pharmaceuticals’ Type 2 diabetes drug, Actos, has been the focus of hundreds of personal injury lawsuits for at least two years. The lawsuits were combined into one multidistrict litigation, MDL 2299, in the court of Louisiana (Lafayette) – the Honorable Rebecca Doherty … [Read more...]

Actos Litigation Will Use New Predictive Coding to Sort Documents

The multidistrict litigation (MDL) against Takeda Pharmaceuticals and their Type 2 diabetes drug, Actos, is taking an interesting step forward with some technological help.The MDL was originally formed to help consolidate several similar cases against Takeda Pharmaceuticals, which allege that their drug Actos led to bladder cancer. Several … [Read more...]

Scottish Study Shows Overdose Drug Helps Patients with Type 2 Diabetes

A study from researchers at the University of the Highlands and Islands shows that a drug used to reverse paracetamol overdose could help prevent blood clots in patients with Type 2 diabetes.Professor Ian Megson, at the University’s Department of Diabetes and Cardiovascular Science, studied the drug N-acetylcysteine’s effect on platelets, which … [Read more...]

Plaintiff Blames Actos for Husband’s Death

In October 2011, Thomas Harber died because he developed bladder cancer. His wife,Nancy, is now filing a lawsuit against Takeda Pharmaceuticals for producing andmarketing Actos, which she alleges caused her husband’s cancer.The lawsuit was filed August 10th, and moved into the multidistrict litigation against Actos in the US District Court in … [Read more...]

Skip Generic Actos, for Health and Legal Reasons

Earlier this month, despite numerous lawsuits against Takeda Pharmaceuticals Actos, the FDA approved pioglitazone – the generic name for Actos – for market in the United States. Now, watchdog group Consumer Reports says the “bargain” should be avoided.For one thing, Consumer Reports points out, the generic version will not currently save patients … [Read more...]

Diabetes Studies Show Lifestyle Changes More Effective than Actos

The generic version of Actos – pioglitazone – has been approved by the FDA for market in the United States. The FDA’s approval comes despite more and more lawsuits against Takeda Pharmaceuticals, manufacturers of brand-name Actos, which allege that the company either knew or should have known about the harmful side effects of their drug before … [Read more...]

BestLawyers.comAVBetter Business Bureau